Nirvana Science, Inc.

About:

Nirvana Science is a technology development company that develops fluorescent dyes with ultra-narrow spectrums.

Website: http://nirvanasciences.com

Twitter/X: nirvanascience

Top Investors: National Institute of Allergy and Infectious Diseases, VentureSouth, NC IDEA, Charlotte Angel Fund

Description:

Nirvana Sciences is a business that develops technologies. New fluorescent dyes with ultra-narrow emissions are being commercialized, which will improve the efficiency of fluorescence-based medical diagnostic and imaging systems and procedures. Ultra-narrow emission dyes enhance multiplexing capabilities, which are greatly wanted by researchers and produce more accurate data for doctors by reducing detection complexities.

Total Funding Amount:

$8.59M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2011-01-01

Contact Email:

support(AT)nirvanasciences.com

Founders:

C. Preston Linn, Patrick Mize

Number of Employees:

1-10

Last Funding Date:

2021-05-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai